Warner-Lambert Company LLC
Warner-Lambert Company LLC, a prominent player in the pharmaceutical and healthcare industry, is headquartered in the United States. Founded in the late 19th century, the company has established itself as a leader in the development and marketing of innovative medicines and consumer health products. With a strong presence in North America and Europe, Warner-Lambert focuses on key therapeutic areas, including cardiovascular health, central nervous system disorders, and consumer health solutions.
Renowned for its flagship products, such as Listerine and Advil, Warner-Lambert distinguishes itself through a commitment to quality and efficacy. The company has achieved significant milestones, including successful mergers and acquisitions that have bolstered its market position. As a subsidiary of Pfizer, Warner-Lambert continues to thrive, contributing to advancements in healthcare and maintaining a reputation for excellence in the pharmaceutical sector.
+60 vs industry average
Warner-Lambert Company LLC’s score of 100 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Warner-Lambert Company LLC?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Warner-Lambert Company LLC yet.
Warner-Lambert Company LLC's reported carbon emissions
Warner-Lambert Company LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Pfizer Inc., and any climate commitments or emissions data would be inherited from its parent organisation.
Pfizer Inc. has established various climate initiatives, including Science-Based Targets Initiative (SBTi) commitments, which are cascaded down to Warner-Lambert. However, specific reduction targets or achievements for Warner-Lambert are not detailed. The initiatives from Pfizer include participation in the Carbon Disclosure Project (CDP), RE100, and the Race to Zero campaign, all aimed at reducing carbon emissions and promoting sustainability.
As of now, Warner-Lambert has not publicly outlined its own distinct climate pledges or reduction targets, indicating a reliance on the broader corporate strategies of Pfizer Inc. for its climate commitments.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Warner-Lambert Company LLC’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Warner-Lambert Company LLC yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Pfizer Inc.
Carbon Disclosure Project
Inherited from Pfizer Inc.The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Pfizer Inc.RE 100
Inherited from Pfizer Inc.Climate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Warner-Lambert Company LLC yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project